URI |
http://vocab.nerc.ac.uk/collection/P02/current/PHWB/ |
Within Vocab |
SeaDataNet Parameter Discovery Vocabulary |
Alternative Labels |
Pharm_WaterBody
|
Definition |
Concentration parameters for substances synthesised by man to modify bodily function or diagnose, cure, mitigate, treat, or prevent disease in either solution or suspension (i.e.includes measurements in both the dissolved and particulate phases) in any body of salt or fresh water. |
Date |
2010-01-27T14:18:1 |
Identifier |
SDN:P02::PHWB |
Note |
accepted |
Has Current Version |
2 |
Version |
1
|
version |
2 |
inScheme |
http://vocab.nerc.ac.uk/scheme/EDMED_DCAT_THEMES/current/ |
Broader
|
P04:G678 |
EARTH SCIENCE > Hydrosphere > Water Quality/Water Chemistry > Contaminants |
Mapping: 170050 |
| D01:D0100001 |
Parameters |
Mapping: 1392481 |
| P36:PHARMS |
Pharmaceuticals |
Mapping: 1601899 |
| L19:005 |
theme |
Mapping: 207006 |
| L04:L04001 |
water body |
Mapping: 801254 |
| P05:007 |
environment |
Mapping: 170068 |
| P05:014 |
oceans |
Mapping: 170069 |
| P22:18 |
Human health and safety |
Mapping: 172839 |
| P22:28 |
Oceanographic geographical features |
Mapping: 172675 |
| P03:C055 |
PCBs and organic micropollutants |
Mapping: 170023 |
| P03:H001 |
Pollution |
Mapping: 170025 |
Narrower
|
| P01:C1HYIBUF |
Concentration of 1-hydroxy-ibuprofen {CAS 53949-53-4} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757026 |
| P01:MUM13270 |
Concentration of 17beta-estradiol {beta-oestradiol CAS 50-28-2} per unit dry weight of suspended particulate material |
Mapping: 482852 |
| P01:CDICLANI |
Concentration of 2,4-dichloroaniline {CAS 554-00-7} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756898 |
| P01:CDCHLANL |
Concentration of 3,4-dichloroaniline {CAS 95-76-1} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756978 |
| P01:CABACAVR |
Concentration of abacavir {CAS 136470-78-5} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757030 |
| P01:CACEBUTO |
Concentration of acebutolol {CAS 37517-30-9} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757050 |
| P01:CALPRAZO |
Concentration of alprazolam {CAS 28981-97-7} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756970 |
| P01:CAMITRIP |
Concentration of amitriptyline {CAS 50-48-6} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756938 |
| P01:CANTHRAQ |
Concentration of anthraquinone {CAS 84-65-1} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756974 |
| P01:IC2W0015 |
Concentration of atenolol {CAS 29122-68-7} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1738062 |
| P01:CATORVAS |
Concentration of atorvastatin {CAS 134523-00-5} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756930 |
| P01:IC2W0017 |
Concentration of bezafibrate {CAS 41859-67-0} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1738106 |
| P01:IC2W0060 |
Concentration of bisoprolol {CAS 66722-44-9} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1737870 |
| P01:CBROMAZP |
Concentration of bromazepam {CAS 1812-30-2} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756966 |
| P01:CBROMUCZ |
Concentration of bromuconazole {CAS 116255-48-2} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756982 |
| P01:CCAFFEIN |
Concentration of caffeine {CAS 58-08-2} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756950 |
| P01:IC2W0075 |
Concentration of carbamazepine {CAS 298-46-4} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1737670 |
| P01:IC2W0046 |
Concentration of cetirizine {CAS 83881-51-0} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1737654 |
| P01:POLLM004 |
Concentration of choline esterase inhibitor per unit volume of the water body [unknown phase] by colorimetric autoanalysis |
Mapping: 422098 |
| P01:CCLENBUT |
Concentration of clenbuterol {CAS 37148-27-9} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756890 |
| P01:CCLOFIB1 |
Concentration of clofibric acid {CAS 882-09-7} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757074 |
| P01:CCLONAZE |
Concentration of clonazepam {CAS 1622-61-3} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757010 |
| P01:CCLOPIDO |
Concentration of clopidogrel {CAS 113665-84-2} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756886 |
| P01:CCLOTRIM |
Concentration of clotrimazole {CAS 23593-75-1} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756954 |
| P01:IC2W0061 |
Concentration of cyproconazole {CAS 94361-06-5} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1737842 |
| P01:IC2W0047 |
Concentration of diazepam {CAS 439-14-5} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1737874 |
| P01:PHWB0022 |
Concentration of diclofenac {CAS 15307-86-5} per unit volume of the water body [dissolved plus reactive particulate <0.4/0.45um phase] |
Mapping: 1614194 |
| P01:IC2W0005 |
Concentration of diclofenac {CAS 15307-86-5} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1737914 |
| P01:CDIETHLA |
Concentration of diethylamine {CAS 109-89-7} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756910 |
| P01:CDFENOCO |
Concentration of difenoconazole {CAS 119446-68-3} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756914 |
| P01:CDISOPYR |
Concentration of disopyramide {CAS 3737-09-5} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757006 |
| P01:CDOXEPIN |
Concentration of doxepin {CAS 1668-19-5} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757058 |
| P01:CECONAZ1 |
Concentration of econazole {CAS 27220-47-9} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757054 |
| P01:MUM13273 |
Concentration of estrone {oestrone CAS 53-16-7} per unit dry weight of suspended particulate material |
Mapping: 482864 |
| P01:CETHALO1 |
Concentration of ethanolamine {CAS 141-43-5} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756846 |
| P01:MUM13271 |
Concentration of ethinyl estradiol {ethinyloestradiol CAS 57-63-6} per unit dry weight of suspended particulate material |
Mapping: 482856 |
| P01:CFENOFEB |
Concentration of fenofibric acid {CAS 42017-89-0} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756850 |
| P01:CFLUOXE1 |
Concentration of fluoxetine {CAS 54910-89-3} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757078 |
| P01:IC2W0050 |
Concentration of fluquinconazole {CAS 136426-54-5} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1738058 |
| P01:CFLUSILZ |
Concentration of flusilazole {CAS 85509-19-9} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756926 |
| P01:CGEMFIBR |
Concentration of gemfibrozil {CAS 25812-30-0} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756878 |
| P01:CHEXACOZ |
Concentration of hexaconazole {CAS 79983-71-4} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756922 |
| P01:CHYDRAZ1 |
Concentration of hydrazine {CAS 302-01-2} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757062 |
| P01:CHYOXBUT |
Concentration of hydroxyterbuthylazine {CAS 66753-07-9} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757042 |
| P01:IC2W0041 |
Concentration of ibuprofen {CAS 15687-27-1} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1737642 |
| P01:CIMIPRAM |
Concentration of imipramine {CAS 50-49-7} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757022 |
| P01:CINDINAV |
Concentration of indinavir {CAS 150378-17-9} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756962 |
| P01:CIPRODIO |
Concentration of iprodione {CAS 36734-19-7} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756902 |
| P01:CKETOPRO |
Concentration of ketoprofen {CAS 22071-15-4} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757090 |
| P01:CLAMIVUD |
Concentration of lamivudine {CAS 134678-17-4} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756906 |
| P01:CLOREZAP |
Concentration of lorazepam {CAS 846-49-1} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757034 |
| P01:CLOSART1 |
Concentration of losartan {CAS 114798-26-4} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756874 |
| P01:CMEPROBA |
Concentration of meprobamate {CAS 57-53-4} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756870 |
| P01:CMEOENE1 |
Concentration of mestranol {CAS 72-33-3} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1755368 |
| P01:CMAXYL01 |
Concentration of metalaxyl {CAS 57837-19-1} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756866 |
| P01:CMETACOZ |
Concentration of metconazole {CAS 125116-23-6} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756894 |
| P01:IC2W0007 |
Concentration of metoprolol {CAS 51384-51-1} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1737918 |
| P01:CMORPHOL |
Concentration of morpholine {CAS 110-91-8} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756934 |
| P01:IC2W0008 |
Concentration of naproxen {CAS 22204-53-1} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1737954 |
| P01:CNELFINV |
Concentration of nelfinavir {CAS 159989-64-7} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756958 |
| P01:CNEVIRAP |
Concentration of nevirapine {CAS 129618-40-2} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757038 |
| P01:CNORDAZE |
Concentration of nordazepam {CAS 1088-11-5} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757018 |
| P01:COMEPRAZ |
Concentration of omeprazole {CAS 73590-58-6} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756946 |
| P01:IC2W0023 |
Concentration of oxazepam {CAS 604-75-1} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1737974 |
| P01:CPCETMOL |
Concentration of paracetamol {CAS 103-90-2} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757086 |
| P01:CPENFLUD |
Concentration of penfluridol {CAS 26864-56-2} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756858 |
| P01:CPRAVAST |
Concentration of pravastatin {CAS 81093-37-0} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757046 |
| P01:IC2W0101 |
Concentration of primidone {CAS 125-33-7} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1737694 |
| P01:CPROPRL1 |
Concentration of propranolol {CAS 525-66-6} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757066 |
| P01:CRANITI1 |
Concentration of ranitidine {CAS 66357-35-5} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756854 |
| P01:CRITONAV |
Concentration of ritonavir {CAS 155213-67-5} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757002 |
| P01:CSALBTMB |
Concentration of salbutamolbase {CAS 35763-26-9} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756862 |
| P01:CSALICY1 |
Concentration of salicylic acid {CAS 69-72-7} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757082 |
| P01:CSAQUINV |
Concentration of saquinavir {CAS 127779-20-8} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756942 |
| P01:CSILDEFA |
Concentration of sildenafil {CAS 139755-83-2} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756882 |
| P01:IC2W0010 |
Concentration of sotalol {CAS 3930-20-9} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1737922 |
| P01:CTAMIXO1 |
Concentration of tamoxifen {CAS 10540-29-1} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757070 |
| P01:CTETRCOZ |
Concentration of tetraconazole {CAS 112281-77-3} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756918 |
| P01:CTHEOPHY |
Concentration of theophylline {CAS 58-55-9} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1757014 |
| P01:CTHIRAM1 |
Concentration of thiram {CAS 137-26-8} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756986 |
| P01:CTIMOLOL |
Concentration of timolol {CAS 26839-75-8} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756998 |
| P01:IC2W0120 |
Concentration of triclosan {CAS 3380-34-5} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1737722 |
| P01:CVINCLOZ |
Concentration of vinclozoline {CAS 50471-44-8} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756990 |
| P01:CZIDOVUD |
Concentration of zidovudine {CAS 30516-87-1} per unit volume of the water body [dissolved plus reactive particulate phase] |
Mapping: 1756994 |
Related
|
| P04:G563 |
EARTH SCIENCE > Human Dimensions > Environmental Impacts > Contaminants |
Mapping: 170051 |
| P04:H028 |
EARTH SCIENCE > Oceans > Water Quality > Ocean Contaminants |
Mapping: 170049 |
| P64:G563 |
EARTH SCIENCE > Human Dimensions > Environmental Impacts > Contaminants |
Mapping: 504084 |
| P64:H028 |
EARTH SCIENCE > Oceans > Water Quality > Ocean Contaminants |
Mapping: 504083 |